← Back to signals
BMY
STRONG BUYBristol-Myers Squibb Company
Health Care
0.52
PEGY ratio
Rank #36
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 72.7% annually over 5 years. Attractive dividend yield of 4.6%.
BMY is trading at 15.4x earnings against 25.0% capped growth (actual 72.7%) + 4.6% yield, giving a PEGY of 0.52. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 72.7%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-02
Valuation
15.4x
P/E Ratio
Growth
72.7%
5yr EPS
Income
4.6%
Div Yield
PEGY Components
PEGY Score0.52
Denominator29.6%
EPS (TTM)$3.57
Market Data
Price$54.95
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.57→0.52(-0.05)
Rank
#49→#36(+13 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only